{
    "clinical_study": {
        "@rank": "107701", 
        "acronym": "ITP0614", 
        "brief_summary": {
            "textblock": "This study aims at analyzing the therapeutic activity of TPO-mimetics Eltrombopag and\n      Romiplostim as bridge therapy for splenectomy in adult patients with primary immune\n      thrombocytopenia."
        }, 
        "brief_title": "TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Adult Patients", 
            "Immune Primary Thrombocytopenia", 
            "Splenectomy", 
            "TPO-mimetics"
        ], 
        "condition_browse": {
            "mesh_term": "Thrombocytopenia"
        }, 
        "detailed_description": {
            "textblock": "Adult immune primary thrombocytopenia is an autoimmune malignancy characterized by platelet\n      destruction and inadequate platelet production. Its incidence is of three cases per 100,000\n      people a year, with a prevalence in women in young and older adults.\n\n      Splenectomy is, still today, the therapeutic approach that offers a bigger guarantee of a\n      long term response (around 60+70%). Nevertheless, splenectomy may be accompanied by\n      peri-operative complications in almost 10% of patients, which in rare cases may be fatal.\n      These are normally hemorrhagic complications due to low platelet count. Thus, a previous\n      therapy to increase platelets is advisable before any splenectomy.\n\n      In patients who are refractory to corticosteroids and immunoglobulins or when its use is not\n      indicated, splenectomy has a potential risk of more complications. Since the last few years,\n      we count with TPO-mimetic drugs, specific for c-MPL receptor, able to stimulate platelet\n      production, such as romiplostim and eltrombopag.\n\n      Nowadays, TPO-mimetics are allowed in Italy when patients refuse splenectomy or when\n      splenectomy is not contraindicated, but being ITP with a low platelet count (<\n      20-50.000/mmc) a potential contraindication to splenectomy due to hemorrhagic events, these\n      drugs should be considered. Nevertheless, there are no data on therapeutic risks and safety\n      of these agents when used for this indication. The aim of the present study is to verify, on\n      an Italian national scale, the frequency of use, its impact and the safety profile."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Persistent or chronic ITP in symtomatic phase.\n\n          -  18 years of age or older.\n\n          -  Indication for splenectomy due to refractory response to a previous therapy.\n\n          -  Have used eltrombopag or romiplostim to increase platelet count before splenectomy.\n\n          -  Have undergone splenectomy.\n\n        Exclusion Criteria:\n\n          -  No informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "ITP adult patients having undergone splenectomy after a bridge therapy with eltrombopag or\n        romiplostim."
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02063763", 
            "org_study_id": "ITP0614"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Adult patients", 
            "Immune primary thrombocytopenia", 
            "Splenectomy", 
            "TPO-mimetics", 
            "Eltrombopag", 
            "Romiplostim"
        ], 
        "lastchanged_date": "June 4, 2014", 
        "link": {
            "description": "GIMEMA Foundation", 
            "url": "http://www.gimema.it"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Giuseppe Caparrotti"
                }, 
                "facility": {
                    "address": {
                        "city": "Aversa", 
                        "country": "Italy"
                    }, 
                    "name": "U.O.C di Ematologia P.O. \"S.Giuseppe Moscati\""
                }, 
                "investigator": [
                    {
                        "last_name": "Giuseppe Caparrotti", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Daniela Esposito", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giuseppe Tarantini"
                }, 
                "facility": {
                    "address": {
                        "city": "Barletta", 
                        "country": "Italy"
                    }, 
                    "name": "UOC Ematologia Ospedale \" Mons. Dimiccoli\""
                }, 
                "investigator": [
                    {
                        "last_name": "Giuseppe Tarantini", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Caterina Buquicchio", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nicola Di Renzo"
                }, 
                "facility": {
                    "address": {
                        "city": "Lecce", 
                        "country": "Italy"
                    }, 
                    "name": "ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE"
                }, 
                "investigator": [
                    {
                        "last_name": "Nicola Di Renzo", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Margherita Giannoccaro", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Paola Lambelet"
                }, 
                "facility": {
                    "address": {
                        "city": "Lido di Camaiore", 
                        "country": "Italy"
                    }, 
                    "name": "Unit\u00e0 Operativa Complessa) - Medicina Generale - Sezione di Ematologia - Ospedale Versilia USL 12 Toscana"
                }, 
                "investigator": [
                    {
                        "last_name": "Paola Lambelet", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Federico Simonetti", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gianluca Gaidano"
                }, 
                "facility": {
                    "address": {
                        "city": "Novara", 
                        "country": "Italy"
                    }, 
                    "name": "S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Universit\u00e0 del Piemonte Orientale Amedeo Avogadro"
                }, 
                "investigator": [
                    {
                        "last_name": "Gianluca Gaidano", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Mariangela Greco", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maria Gabriella Mazzucconi"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 degli Studi \"Sapienza\" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia"
                }, 
                "investigator": {
                    "last_name": "Maria Gabriella Mazzucconi", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Francesco Zaja"
                }, 
                "facility": {
                    "address": {
                        "city": "Udine", 
                        "country": "Italy"
                    }, 
                    "name": "Clinica Ematologica - Policlinico Universitario"
                }, 
                "investigator": {
                    "last_name": "Francesco Zaja", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Dino Veneri"
                }, 
                "facility": {
                    "address": {
                        "city": "Verona", 
                        "country": "Italy"
                    }, 
                    "name": "Universit\u00e0 degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi"
                }, 
                "investigator": [
                    {
                        "last_name": "Dino Veneri", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Giovanni Pizzolo", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Use of TPO-mimetics to Prepare for Splenectomy in Adult Patients With Primary Immune Thrombocytopenia. Brooklyn Observational Retrospective Study.", 
        "overall_contact": {
            "email": "e.crea@gimema.it", 
            "last_name": "Enrico Crea"
        }, 
        "overall_official": {
            "affiliation": "Clinica Ematologica, DISM, Azienda Ospedaliera Universitaria S. M. Misericordia", 
            "last_name": "Francesco Zaja, Pr.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "According to platelet count and presence or absence of hemorrhagic events.", 
            "measure": "Number of patients responding to TPO-mimetics", 
            "safety_issue": "No", 
            "time_frame": "Six months."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02063763"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of patients on TPO-mimetics eltrombopag and romiplostim as bridge therapy before splenectomy.", 
                "safety_issue": "No", 
                "time_frame": "Six months."
            }, 
            {
                "measure": "Frequency and ways of administration.", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Number and seriousness of hemorrhagic, thrombotic and infectious events at 30 days from splenectomy.", 
                "measure": "Number of hemorrhagic events.", 
                "safety_issue": "No", 
                "time_frame": "At thirty days from splenectomy."
            }, 
            {
                "description": "NCI CTCAE v. 4.0", 
                "measure": "Frequency of toxicity.", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }
        ], 
        "source": "Gruppo Italiano Malattie EMatologiche dell'Adulto", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gruppo Italiano Malattie EMatologiche dell'Adulto", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "June 2014"
    }
}